DatasetName,S100A11_S(5),S100A11_S(101) S100A11_S(3) S100A11_S(6) S100A11_S(71) S100A11_T(105) S100A11_Y(30) S100A11_Y(32)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,0.5021067787420027
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,0.4838556433317627
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,0.5122398586550098
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,,0.5011936396753599
JJ2018_Ratio H/M normalized pP2,0.7836353378483865,0.5203133724585947
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,0.6576554910528672,0.5046436491722665
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,0.5205483453447777
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5114278794155079
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.7724260618550571,0.5360337169019308
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5280458807591821,0.5044507239559607
FSO2013_Ratio M/L normalized Rep1___1,,0.5205577599336528
SAS2015_AZD/DMSO_Exp3,0.3635600981404916,0.4896700195695858
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.556970925664643,0.488808055094057
WZ2023_Pu_010_30min,0.4200034287409957,0.5248065076961212
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5171974713492663
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.72555415461692,0.5052336785025624
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,,0.5034701568210932
JJ2018_Ratio H/L normalized___1,0.4312399492444211,0.513789713455843
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.5300607653552389,0.48576212259807033
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.6785483904375915,0.5306497162006012
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.414410629416952,0.5244362976755393
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.6887128115308673,0.4985667931718382
WZ2023_Pu_005_10min,0.3969306022753011,0.5242327928481643
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.49863196986817365
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.4312034802029337,0.5247185754278073
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.621528457121968,0.5146239532351103
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.3364949625082303,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.3800604966032416,0.500520256998456
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,0.3369215803088908,0.5072108449698425
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,,0.49787027761156083
FSO2013_Ratio H/L normalized Rep1___1,,0.5362214929296317
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.7048652618106385,0.5164200439962429
HS2024_3_B_N1,,0.5206186501001916
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.4115634263986422,0.5241840640168042
CK2022_11 40-1,,0.4982871553991498
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,,0.5291965087557354
WZ2023_Pu_005_20min,0.42539311980764,0.5237492619747225
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.3525315994992822,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.3879215017934583,0.4916928161008419
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.46431518566534
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.4547209797777608,0.49087580944704406
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5760907977529605,0.49028051627185293
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,0.49280285440011456
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.6469333225368767,0.519236884645622
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,,0.5011702428549196
PG2020_Intensity Mock_10h_D,,0.4857825628824509
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.4440717654826362,0.4645512925415521
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.4426196933143952,0.4904568038054366
RCJD2014_5min_1,,0.49601175033860134
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.4198374934861829,0.5017632922360981
CR2017_Ratio Replicate 3.3,0.3652637926833812,0.5193768441622353
PG2020_Intensity 2h_C,,0.4968415478263077
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.7392535855714627,0.528356981568551
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.4211879847027546,0.46498565335833725
RN2012_L11,0.4313577845178151,0.4853865370030285
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,0.651570332098458,0.5134268055711108
AH2018_LFQ_M_2_C,,0.4828099129118376
CK2022_3 40-1,,0.4945965900183508
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.703878706655036,0.5279215838330572
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,0.4966715366509677
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.4024594804572567,0.4930354839754654
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.6701785034252055,0.5142130888435638
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.4630636226381699,0.49795590889397495
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,
HS2024_8_I_T3,0.5601180778237681,0.5021640560324727
CF2017_EOC 3,0.5076715867540035,0.4981773472787596
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.4341479403026879,0.4589483954331265
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4150634024818648,0.5245877016751687
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.4943157194908912
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,,0.49685228061439757
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,0.48325874613036285
RAM2015_Log2 A,,0.512283187004577
HS2024_8_PD_T1,0.6058493512399313,0.5048256382519618
JJ2018_Ratio H/L normalized pP2,0.7933546917200749,0.49547261384252
CF2017_OSE 27,,0.49076681818519036
KS2014_Intensity E15_2,,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5706622576021743,0.5005513471078575
HS2024_7_I_T1,0.3614284271639467,0.49272990225986113
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,0.4638895166873919
SR2019_JIMT1_Biol_repl_1,,0.4881876967387007
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,0.5077166812309767
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.7166208057119606,0.5317682552395213
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,0.5193573830882966
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5567292614150984,0.4887498694939163
HS2024_6_B_N1,,0.5003623804468057
KBE2022_Log2_Ex_27_T,0.6909723040784076,0.49699061475137885
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.49348944858796834
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,0.48173018290841735
FSO2013_Ratio M/L normalized Rep2,,0.5162852499309742
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,0.5039199539649175
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.4833272766633398
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.3898525143412374,0.48051253736535715
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,,0.48965481535445327
DL2023_control-1,,
AR2021_ALG 10 μM,,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5029293393645428,0.5041882043798481
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.49432666188949426
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,0.512058590993158
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,0.5017544437954565
GF2025_P8_Sph,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.4560322817700336,0.487380339222498
AH2018_SILAC_2_N,,
CK2022_11 200-1,,0.5056877637415623
CK2022_12 200-1,,0.5083440659703854
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,0.5051435440171412
WZ2023_Su_010_20min,0.4130249872333618,0.5238668482432137
AH2018_TMTMS2_2_N,,0.5036413582848324
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.711155528356126,0.5085066982233591
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.4985689999959738
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,0.4660666194976114
CK2022_14 200-1,,0.4829200027868627
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.3250949083389002,0.49560497430220635
JW2021_After_2,,0.5128174438643489
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,,0.5012805227145385
GF2025_P1_Sph,,0.509023898754127
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,0.4904962410675213
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.376874159781516,0.5233057106152309
CF2017_EOC 1,0.5680678551211812,0.5085634574126295
CK2022_3 200-1,,0.5006888061036332
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,0.5038318664391485
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.422563548898591,0.48343731639125276
HS2024_5_B_T1,0.640648792484333,0.5379923268528464
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,0.5290954116762069
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.4949211380287774
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.499117085063038
JW2021_Before_2,,0.4992027287187447
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,,
HS2024_4_B_T1,0.4776611528730113,0.5136698302002057
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,0.5113558613133137
CR2017_Ratio Replicate 3.2,0.447593004697672,0.49753620120679376
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,0.46219706117037607
CK2022_13 200-1,,0.481471589391827
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.4950785071327609,0.48231246428882896
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,0.48496482255913564
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.3772366346006551,0.5244644997689523
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.7085430383501083,0.5121797852626034
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,,0.49111479263099556
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.7609046165554351,0.508447200587356
AH2018_LFQ_M_1_N,,0.510365532239739
KBE2022_Log2_Ex_27_U,0.6936591512124626,0.4960871348452672
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,0.48123252752911705
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.3938582958939951,0.4909070375233651
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,0.5437628798060943,0.5048673314494352
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.6999382891484818,0.5262787605577942
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5700871503374892,0.49233729243891944
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.4327575532350076,0.49099193462011387
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.4880226335538511
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.4970225949605013
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,
HH2022_Reporter intensity 6,,0.5126407372344772
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,0.5055106179403889
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,,0.5082460648251221
GF2025_P3_Adh,,0.49502354071358046
SR2019_JIMT1_Biol_repl_2,,0.5087164543315366
AH2018_TMTMS2_1_C,,0.49727452434938396
RM2024_Intensity D0-1___2,,
LY2019_P4+,,
KBE2022_Log2_Ex_19_U,0.7722233516707135,0.5067632242470922
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,0.5176054651865651
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5157414127878535
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,0.46851498924653306
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.4128056858734252,0.4920854135606251
AH2018_LFQ_1_X,,0.5140206395572929
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,0.5145680563235003
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,,0.4907852085263164
HH2022_Reporter intensity 1,,0.5130382733339582
HH2022_Reporter intensity 2,,0.5123841689530862
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,0.49907046564824903
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5973638488884293,0.5131553112872516
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5908753645805269,0.5114425614692999
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,0.49664577966006623
AR2021_KD 72h,,0.5079493628236349
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.7891089875327555,0.5352819245246329
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.7130488375721663,0.5114198449262238
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.726463340267076,0.5186146572423376
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,0.4587450553365607
PG2020_Intensity Mock_10h_C,,0.47103325669512025
CF2017_OSE 29,,0.4740612073994253
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5492407378940565,0.5059049472483524
PG2020_Intensity 10h_A,0.3078335721850226,0.4950326198296546
RN2012_L12,0.4382571198106454,0.4850008013306931
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,0.6304961722790471,0.4935659577205084
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5194005314443818
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.49055827492428383
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.4824056303152554,
KS2014_Intensity pY_PV3,,0.5205450424033264
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.4024472444499265,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.7849535375722054,0.5402166708720685
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,,0.4914627929292031
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.8199667201195614,0.5330187986320639
CK2022_7 200-1,,0.49449725307639053
CK2022_5 200-1,,0.4964687941498505
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5297966775743952
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.7025483658555302,0.49896282730810565
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,0.5171171429568139
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5072210539939486
SAS2015_PLX/DMSO_Exp1,0.3539201647871759,0.4994151696949546
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.4558958020639839,0.4873413549790536
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5316534227832981,0.49377084311091596
FSO2013_Ratio H/L normalized Rep3,,0.510012589268473
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,0.5087026896905134
JJ2018_Ratio M/L normalized,0.3900695723558446,0.5212880600865563
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,0.49856428364999283
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,0.4894647945460132
KBE2022_Log2_Ex_9_T,0.702488661171357,0.5114228233433474
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,0.500597560258802
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,
WZ2023_Pe_025_20min,0.4201476170626367,0.5247227148802095
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.505708876864502
HS2024_4_I_N2,0.7399635073339893,0.5300615279591089
AH2018_TMTMS2_3_N,,0.5045208809893386
RN2012_H06,0.4301700298217586,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5813482037480894,0.5072749100176026
WZ2023_Su_005_30min,0.3974684673240998,0.523980405990797
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.4936688409594437
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5339790943225179,0.5013122674780917
WZ2023_Su_025_10min,0.3712767573868524,0.5251532976076545
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.421142033581575,0.5246275602709458
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.6643815768635883,0.5317483218378576
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,,0.46739610065863635
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.4871235585540211,0.4757716632521034
LY2019_P7+,,
EP2017_Untreated R#1 normalized log2 ratio,0.5560479184344008,0.49891565990379755
RN2012_L10,0.4481662512125837,
PG2020_Intensity 4h_C,0.4430386187848342,0.4821776588757907
EP2017_Mitotic R#3 normalized log2 ratio,0.4581663804919895,0.48260674870631026
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.7624752942798527,0.5354485061082552
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.522293360145325,0.5166033021249918
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,0.49004977382572
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.7910472275465801,0.49539771715103803
HS2024_8_I_T2,,0.4841438761921387
KBE2022_Log2_Ex_6_U,0.7491011571428982,0.5325065437889299
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5204014288019748,0.5031226394232806
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.4830982054835143
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4338445576906334,0.499750139751965
GF2025_P9_Sph,,
CK2022_6 200-1,,0.494888976808798
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,0.48889172607015036
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.6292814179877156,0.5205942748549919
SAS2015_AZD/DMSO_Exp1,0.3286375918995078,0.48351924105727656
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,0.3843694807021767,0.5078537480352395
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.3068203410934901,0.4885853677311057
EP2017_Untreated R#3 normalized log2 ratio,0.4307604992919551,0.4991068813733873
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.493982462489781
KS2014_Intensity pY_C4,,0.501318897020715
CR2017_Ratio Replicate 3.5,0.5305742149317046,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.6870113634349289,0.5250982324712832
EP2017_Pervanadate R#2 normalized log2 ratio,0.6803077025979055,0.536721227307605
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.5312347551059904
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.4097894008034838,0.4900502077466675
KBE2022_Log2_Ex_29_T,0.7018905032122849,0.507414962439176
HS2024_7_I_T2,,0.49352354801029097
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.570499795808232,0.5057790448883294
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.3473454355378481,0.4926303448235893
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5059074337500965,0.4848737566435747
PG2020_Intensity CT_C,0.3918396560195114,0.49150320479601944
ZCP2016_Ratio H/L Rep 1,0.5455877172312835,0.505921049288575
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,0.5165146716450452
KBE2022_Log2_Ex_39_U,0.6696055457760687,0.48777083976027147
EP2017_Untreated R#3 log2 ratio,0.4307360510176046,0.49906834580253623
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4493921344707739,
HS2024_8_PD_T2,0.5473269843470431,0.5024760241127628
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,0.4890831176660973
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.7617342858268078,0.5367826502024039
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,0.5166349220476517
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.4127769742487125,0.49021887527064695
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.48780258226558165
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.6228499006341217,0.5179628789868201
HS2024_3_PD_T3,,0.5263769193811673
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,0.5094649850043422
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.7682630011450947,0.5083708148965546
CK2022_2 16-1,,
RAM2015_Log2 B,,0.5117703355403325
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.4295818119657761,0.4817890258371137
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.6485224648211452,0.5058998875485909
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.4907053961966036,0.4993520000422086
PG2020_Intensity Mock_10h_B,,0.49847766650928993
WZ2023_Su_025_30min,0.4266274473096704,0.5252636630703545
AH2018_LFQ_4_N,,0.5043416318258115
CR2017_Ratio Replicate 1.2,0.3234742403501013,0.5026618744988541
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,0.5189466101990192
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,0.5091184127417405
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.6725685060401325,0.5254468961864577
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5700305117875848,0.5203799992220681
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,0.5082772614696475
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5176045083081156,0.48567609103559983
AH2018_LFQ_2_X,,0.5131591253962915
PG2020_Intensity 2h_B,0.4487398782176056,0.4938583775348695
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,,
GF2025_P3_Sph,,0.5155556695561515
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.4964603265464037
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.7570780717971637,0.5201004904353703
CR2017_Ratio Replicate 2.4,0.3040892207008437,
ZQ2022_N1,,
LY2019_P6-,,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.4706030427414254,
AH2018_LFQ_3_N,,0.5026975725085402
RKK2015_TNF-α/IKKb,,0.4893862531767091
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.6799460512756698,0.511280332971981
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.3001492549412061,0.4825798439877242
CK2022_7 40-1,,0.4889768770202498
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.4658943614631983,0.48644145295872043
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.4320952807470672,0.5137116313564345
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,0.5292173706817752
WZ2023_Su_025_20min,0.4121600159383896,0.5239542683638944
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,0.5330006796239355
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.48279644558982415
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.5661451831708351,
PG2020_Intensity 10h_D,,0.48597854994927625
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,0.5127768409335947
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.6780215422970027,0.5297708808064433
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,0.48403623322623296
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,0.49677425004163694
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.4892478271415051,0.4911612065672936
CK2022_6 40-1,,0.4902935893368114
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.6562448534422674,0.5022765105601208
LY2019_P3-,,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4140369165521417,0.5254923493303925
HS2024_8_PD_T3,0.5332804193486813,0.4994348505591139
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4270034569727731,0.48509588474872267
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.4152895193366122,0.5245077874027093
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,0.510669034636006
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,,0.4976574330933392
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,,0.5164422315436938
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.7812689720576811,0.5203141387491781
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,0.46742555064394875
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.4760583869084402
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,0.5226388970951895
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.7086345883199284,0.5099327476471144
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.3877604818643316,0.4738887027767533
LY2019_P2-,,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,0.2799626601426599,0.4816594455324434
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4071539998984505,0.5240124417011175
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,0.47547841586314593
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.6006564143760215,0.4910724625119573
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.4926069717717077
SR2019_MCF10A_Biol_repl_4,,0.4745114673715269
KS2014_Intensity pY_C5,,0.5134090710568633
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,0.4710021921412835
HS2024_5_B_T2,0.5407537310991742,0.5019013961674532
HS2024_6_I_T1,,0.48209589124336755
HS2024_5_B_T3,0.5879044114772508,0.5052900651571164
JJ2018_Ratio H/M normalized pP1___1,0.3600968360483403,0.5061450839308897
KBE2022_Log2_Ex_36_U,0.7226468220709118,0.5154861333318776
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4822572588621197,0.48884544853899153
KBE2022_Log2_Ex_36_T,0.7132791482441749,0.5216984851674646
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4019041824896084,0.5247367658679254
KS2014_Intensity C2,,
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.6940459955849725,0.515254934931306
CK2022_9 200-1,,0.5069804500997186
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5053633009385744
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.3623429788557911,0.5053635188676867
RBK2021_1332T Late,,
LY2019_P1-,,
RKK2015_TNF-α/basal.1,,0.4651221616599424
RKK2015_TNF-α/TNF-α+SC-514,,0.4987380059062505
CR2017_Ratio Replicate 2.5,0.3854094416757119,
HS2024_3_I_T3,0.5091624901592987,0.47874176176522426
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.6696588747215353,0.4837580722017783
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5561615057713079,0.4988216081311008
RKK2015_SC-514/basal,,0.48873676678207695
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.4063087519504814,0.5249760817974594
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.6053570442210303,0.511672371098187
KS2014_Intensity N1,,0.4919759720948506
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.4616330680346837,0.5014344519869958
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.4289454991834494,0.48204652166502776
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.4821192150067032,0.4896710066926192
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,0.7466362620041609,0.5108935863340283
RCJD2014_15min_2,,0.5004786151981148
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.431316340675797,0.48968360607748374
HS2024_5_B_N2,,0.48285462196841333
HS2024_5_I_N1,,0.49940291934202946
HS2024_6_I_N1,,0.5084910492931811
AR2021_KD 48h,,0.5039179325957389
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.6932581430912017,0.521141313844317
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.422635185732409,0.5243061591483923
KBE2022_Log2_Ex_29_U,0.703320842435014,0.5041598532327142
HS2024_7_B_T1,0.4202451966847775,0.48720501640347075
AH2018_LFQ_M_2_X,,0.5166940284052015
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,,0.4838168184924116
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.7417873072288538,0.5110168716219233
JJ2018_Ratio M/L normalized pP3___1,0.3318289032181203,0.5072696791267123
KBE2022_Log2_Ex_34_T,0.6916903443150308,0.5002016910891386
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.4995230354269856
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.4142826901221208,0.5231481661580062
RN2012_H01,0.5268084342429823,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,0.5318675525986345
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.6652616884639468,0.5323876260868889
HS2024_8_B_T3,,0.49512611197751966
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.7588359331690953,0.5356273459996753
WZ2023_Pe_010_20min,0.3998826637393367,0.5238170500939585
KS2014_Intensity pY_C6,,0.5120949867847459
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,0.4864779540046272
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,0.492917043475321
KS2014_Intensity C1,,
FSO2013_Ratio H/M normalized Rep3___1,,0.49710237071011204
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,,0.5057289018792485
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.7948801419419558,0.5446075419666395
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.3817410614596886,0.5244401978425124
PG2020_Intensity 6h_C,0.5127688399490619,0.48828661780218846
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.761555383890805,0.5199805694973448
AH2018_LFQ_M_3_N,,0.5067538505217224
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,,0.506650987991143
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,0.5149897065422772
HS2024_3_I_N2,,0.5065967147444125
GF2025_P8_Adh,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.49707594006175027
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5032668186586294
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.3438940910459145,0.49062707669229716
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4592529524713846,0.504467655563144
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5451473310533081,0.4948239086199299
AR2021_L41 10 μM,,
CF2017_EOC 2,0.4662280840805107,0.49747886525643953
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,0.5211967163263925
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,0.513110618519449
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,,0.5070216578294305
AR2021_L41 1 μM,,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,,0.49983515084683067
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.8121475162889281,0.5429780614363098
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,0.49487523623330915
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.383405474173816,0.49887148606891313
SAS2015_PLX/DMSO_Exp3,0.3433940304060701,0.49628988883399466
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.4880506067285533
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.4115283815874028,0.5248438725163981
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,0.5160133376215208
FSO2013_Ratio M/L normalized Rep3___1,,0.5015778180883937
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.5396448445004142,0.4910532008276796
CF2017_EOC 4,0.4484800136237027,0.506749044339428
JJ2018_Ratio H/L normalized pP1___1,0.6607591632937004,0.521317830536199
WZ2023_Pe_010_30min,0.3687564767589504,0.5239769122448299
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.49852524275299986
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,0.3604539546503025,0.5064571477968312
CK2022_16 40-1,,0.48265043856528056
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,,0.4914359934511485
AH2018_LFQ_3_X,,0.5162362672549307
UK2020_UA_3,,
LY2019_P7-,,
GF2025_P5_Adh,,0.48351683599620915
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5103553018667697
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.377452681018142,0.5008650932504611
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.6787344974810644,0.5105419145588651
PG2020_Intensity CT_B,0.3122025543543989,0.48411277153760535
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,0.5139272513899602
JW2021_Before_3,,0.5002631948257416
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,0.5168551614758184
AH2018_LFQ_3_C,,0.47957425778642016
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5195369481161201
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,0.5277249568966969
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5130717396992824
RB2022_2_PreEndurance,,
JW2021_Before_1,,0.5070821124769915
KBE2022_Log2_Ex_25_T,0.6905382849370338,0.49315357697691997
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,0.3868837231401773,0.5213444271046742
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.6566314742602323,0.5006549701137285
KS2014_Intensity pY_N1,,0.5013092251069138
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.511896947860779,0.494045539733945
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.465695716941678,0.49503633212353265
AH2018_TMTMS2_1_X,,0.5065313035389256
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.6366033034515606,0.4960288860867438
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,0.5054572029748565
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,0.5312403680227706
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.4263101548653463,0.4761924270953789
HS2024_4_I_T3,0.6826886748939379,0.5220914238119522
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,0.4758313096208474
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,0.49090841228234255
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.4932396355051536,0.48328070258150874
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.6909260073082074,0.5097000056307511
EP2017_Untreated R#2 normalized log2 ratio,0.5977780501240998,0.5131588906359307
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,
HS2024_5_I_N2,,0.49890753770954455
SAS2015_PLX/AZD_Exp3,0.4079314157344521,0.5140062267522493
EP2017_Pervanadate R#2 log2 ratio,0.679769278261945,0.5360587186690398
AS2011_Ratio H/L Normalized RNAi_2_1,,
